tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SLRX Stock Latest News

Clinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting
Press ReleasesClinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting
1M ago
SLRX
Salarius Pharmaceuticals announces presentation of data on seclidemstat
PremiumThe Fly
Salarius Pharmaceuticals announces presentation of data on seclidemstat
1M ago
SLRX
Salarius Pharmaceuticals trading halted, news pending
PremiumThe Fly
Salarius Pharmaceuticals trading halted, news pending
1M ago
SLRX
Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split
PremiumPress Releases
Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split
1M ago
SLRX
Salarius Pharmaceuticals announces 1-for-8 reverse stock split
PremiumThe Fly
Salarius Pharmaceuticals announces 1-for-8 reverse stock split
1M ago
SLRX
Aprea Therapeutics appoints Mirza as Chief Medical Officer
PremiumThe FlyAprea Therapeutics appoints Mirza as Chief Medical Officer
3M ago
APRE
SLRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
AMPE
BLRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
CYTO
ESPR
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4M ago
SLRX
Salarius Pharmaceuticals Announces Executive Restructuring and Cost-Saving Measures
PremiumCompany Announcements
Salarius Pharmaceuticals Announces Executive Restructuring and Cost-Saving Measures
5M ago
8K
SLRX
Salarius announces additional cost saving measures, CEO transitions to part-time
PremiumThe Fly
Salarius announces additional cost saving measures, CEO transitions to part-time
5M ago
SLRX
Salarius issued U.S. patent for next-gen targeted protein degraders
PremiumThe Fly
Salarius issued U.S. patent for next-gen targeted protein degraders
6M ago
SLRX
Salarius announces Phase 1/2 trial of seclidemstat resumes patient enrollment
PremiumThe FlySalarius announces Phase 1/2 trial of seclidemstat resumes patient enrollment
7M ago
SLRX
Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment
PremiumPress Releases
Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment
7M ago
SLRX
SLRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SLRX Earnings this Week: How Will it Perform?
8M ago
SLRX
Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
PremiumPress Releases
Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
8M ago
SLRX
Salarius Pharmaceuticals completes FDA Type B meetng for seclidemstat
PremiumThe Fly
Salarius Pharmaceuticals completes FDA Type B meetng for seclidemstat
8M ago
SLRX
Salarius Pharmaceuticals downgraded with programs halted at Ladenburg
PremiumThe Fly
Salarius Pharmaceuticals downgraded with programs halted at Ladenburg
11M ago
SLRX
Salarius Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
PremiumThe Fly
Salarius Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
11M ago
SLRX
Salarius Pharmaceuticals explores strategic alternatives, begins cost savings
PremiumThe FlySalarius Pharmaceuticals explores strategic alternatives, begins cost savings
11M ago
SLRX
Salarius Pharmaceuticals reports Q2 EPS ($1.43), consensus ($1.30)
PremiumThe Fly
Salarius Pharmaceuticals reports Q2 EPS ($1.43), consensus ($1.30)
11M ago
SLRX
Salarius Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides a Business Update
PremiumPress Releases
Salarius Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides a Business Update
11M ago
SLRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >